Efficacy and safety of a novel TKI (anlotinib) for the treatment of advanced digestive system neoplasms: a systematic review and meta-analysis

ObjectiveTo systematically evaluate the efficacy and safety of anlotinib targeted therapy for the treatment of patients with advanced digestive system neoplasms (DSNs).MethodsClinical trials were extracted from PubMed, the Cochrane Library, Web of Science, Embase, China National Knowledge Infrastruc...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Changhui Zhou, Weihua Wang, Ying Mu, Min Meng
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2024-08-01
Schriftenreihe:	Frontiers in Immunology
Schlagworte:	anlotinib target therapy conventional treatment digestive system neoplasms meta-analysis
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1393404/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!